Ortho Innovation Talks provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of the industry's top orthopedic companies.
In Season 2, we feature emerging leader Enovis. We explore hip, knee, shoulder, and elbow reconstructive joint surgeries, bracing and supports, foot and ankle solutions, ASCs, and digital health technology all from the viewpoint of Enovis's senior leadership.
In Season 1, Zimmer Biomet provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of Zimmer Biomet’s senior leadership.
All content for Ortho Innovation Talks: Enovis & Zimmer Biomet is the property of DeviceTalks Podcast Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Ortho Innovation Talks provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of the industry's top orthopedic companies.
In Season 2, we feature emerging leader Enovis. We explore hip, knee, shoulder, and elbow reconstructive joint surgeries, bracing and supports, foot and ankle solutions, ASCs, and digital health technology all from the viewpoint of Enovis's senior leadership.
In Season 1, Zimmer Biomet provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of Zimmer Biomet’s senior leadership.
S2 E2 - Can Enovis’ ARVIS AR technology help surgeons rethink precision and cost in the ASC era?
Ortho Innovation Talks: Enovis & Zimmer Biomet
40 minutes 48 seconds
4 months ago
S2 E2 - Can Enovis’ ARVIS AR technology help surgeons rethink precision and cost in the ASC era?
In this episode of Ortho Innovation Talks, Marc Mackey, senior vice president and general manager of Enabling Technologies at Enovis, breaks down how his team is building a next-generation platform that prioritizes precision, efficiency, and value. Mackey explains how augmented reality and AI are making orthopedic surgeries more accurate, efficient, and accessible — especially in outpatient environments like ASCs.
He details the evolution of Enovis’ AR-based navigation platform, ARVIS, from early prototypes to its current compact, cost-effective design that eliminates the need for bulky hardware. As adoption grows, Mackey highlights how surgeons are leveraging ARVIS for soft tissue balancing, gap assessment, and patient-specific alignment, while AI streamlines surgical planning and imaging segmentation.
This conversation comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help support you, visit them at https://regenity.com.
Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe.
Ortho Innovation Talks: Enovis & Zimmer Biomet
Ortho Innovation Talks provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of the industry's top orthopedic companies.
In Season 2, we feature emerging leader Enovis. We explore hip, knee, shoulder, and elbow reconstructive joint surgeries, bracing and supports, foot and ankle solutions, ASCs, and digital health technology all from the viewpoint of Enovis's senior leadership.
In Season 1, Zimmer Biomet provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of Zimmer Biomet’s senior leadership.
